Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,142 | 55,852 | 75,561 | 142,423 | 106,889 |
| Marketable Securities | 286,354 | 229,373 | 244,200 | 230,166 | 179,605 |
| Receivables | 9,679 | 8,372 | 8,587 | 2,626 | 739 |
| Other current assets | 2,281 | 3,995 | 3,831 | 4,834 | 2,347 |
| TOTAL | $359,492 | $303,884 | $337,913 | $386,357 | $293,270 |
| Non-Current Assets | |||||
| PPE Net | 27,330 | 23,140 | 28,702 | 19,856 | 16,698 |
| Investments And Advances | 108,194 | 159,083 | 150,819 | 102,296 | 19,795 |
| Other Non-Current Assets | 34,123 | 32,924 | 26,380 | 6,475 | 6,224 |
| TOTAL | $169,647 | $215,147 | $205,901 | $128,627 | $42,717 |
| Total Assets | $529,139 | $519,031 | $543,814 | $514,984 | $335,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,851 | 4,204 | 4,412 | 5,214 | 4,230 |
| Accrued Expenses | 16,534 | 14,189 | 17,164 | 13,306 | 12,023 |
| TOTAL | $24,661 | $21,390 | $22,176 | $19,120 | $16,853 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 600 | 600 | 600 | 600 |
| Other Non-Current Liabilities | 6,553 | 7,255 | 2,505 | 691 | 720 |
| TOTAL | $9,886 | $10,588 | $12,790 | $1,807 | $1,912 |
| Total Liabilities | $34,547 | $31,978 | $34,966 | $20,927 | $18,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,807 | 36,637 | 36,419 | 35,840 | 32,309 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -116,774 | -115,317 | -83,016 | -87,322 | -68,120 |
| Other shareholders' equity | 471 | -59 | -720 | -874 | -771 |
| TOTAL | $494,592 | $487,053 | $508,848 | $494,057 | $317,222 |
| Total Liabilities And Equity | $529,139 | $519,031 | $543,814 | $514,984 | $335,987 |